Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027563
Filing Date
2021-05-13
Accepted
2021-05-13 16:16:28
Documents
40
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20210331.htm   iXBRL 10-Q 914322
2 EX-31.1 mnov-ex311_7.htm EX-31.1 10996
3 EX-31.2 mnov-ex312_8.htm EX-31.2 11011
4 EX-32.1 mnov-ex321_9.htm EX-32.1 7895
5 EX-32.2 mnov-ex322_6.htm EX-32.2 7887
  Complete submission text file 0001564590-21-027563.txt   3015250

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnov-20210331.xsd EX-101.SCH 23590
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20210331_cal.xml EX-101.CAL 24171
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20210331_def.xml EX-101.DEF 66654
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20210331_lab.xml EX-101.LAB 220478
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20210331_pre.xml EX-101.PRE 157507
11 EXTRACTED XBRL INSTANCE DOCUMENT mnov-10q_20210331_htm.xml XML 314599
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 21919857
SIC: 2834 Pharmaceutical Preparations